JEFFREY B KINDLER
CIK 1174454 · Executive Chairman · last filed 2026-05-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$24.59M
Companies
10
Total Filings
172
Lifetime Open-Market Net
-$1.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) Delisted | Director | — | $52.95 | — | $0 | 9 | 2026-05-05 |
| PGEN | Director | 202,100 | $4.45 | $899.3K | -$1.71M | 17 | 2026-03-16 |
| PRAX | Director | 688 | $266.58 | $183.4K | $0 | 1 | 2026-02-10 |
| PRGO | Director | 10,559 | $10.99 | $116.0K | -$497.5K | 15 | 2025-05-16 |
| PPD, Inc. (PPD) Delisted | Director | 0 | $47.28 | $0 | $499.5K | 4 | 2021-12-08 |
| VTVT | Executive Chairman | 35,000 | $32.77 | $1.15M | $0 | 7 | 2020-06-15 |
| SIGA | Director | 127,339 | $4.32 | $550.1K | $0 | 10 | 2020-05-22 |
| PRECIGEN, INC. (XON) Delisted | Director | 84,040 | — | — | $627.7K | 16 | 2019-03-26 |
| CMG | Director | 313 | $32.23 | $10.1K | $0 | 2 | 2013-05-17 |
| PFE | Former Chairman & CEO | 827,296 | $26.21 | $21.68M | $0 | 91 | 2010-12-17 |
Recent Filings · Page 2 of 18
172 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-03 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-10 | PRGO | Sell (S) | −17,598 | -$497.5K | EDGAR |
| 2024-07-02 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-16 | PRGO | Mixed | +4,557 | $137.7K | EDGAR |
| 2024-03-18 | PGEN | Grant (A) | +48,251 | $69.0K | EDGAR |
| 2024-03-12 | PGEN | Exer (M) | +106,837 | $0 | EDGAR |
| 2023-12-29 | PGEN | Sell (S) | −96,686 | -$136.3K | EDGAR |
| 2023-06-14 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | PRGO | Mixed | +4,044 | $132.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.